Chemours Dividends and Buybacks
Dividend criteria checks 2/6
Chemours is a dividend paying company with a current yield of 3.13%. Next payment date is on 16th June, 2025 with an ex-dividend date of 16th May, 2025.
Key information
3.1%
Dividend yield
-0.4%
Buyback Yield
| Total Shareholder Yield | 2.8% |
| Future Dividend Yield | 4.6% |
| Dividend Growth | 16.0% |
| Next dividend pay date | 16 Jun 25 |
| Ex dividend date | 16 May 25 |
| Dividend per share | n/a |
| Payout ratio | 535% |
Recent dividend and buyback updates
Recent updates
We Like The Quality Of Chemours' (NYSE:CC) Earnings
May 14
Chemours: Dividend Cut May Signal A Bottom Is Near
May 07Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?
Apr 25What Is The Chemours Company's (NYSE:CC) Share Price Doing?
Mar 19It's Down 27% But The Chemours Company (NYSE:CC) Could Be Riskier Than It Looks
Mar 04Chemours (NYSE:CC) Seems To Be Using A Lot Of Debt
Jan 24Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?
Jan 08Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet
Dec 05Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright
Nov 21Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye
Nov 12Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?
Sep 25
Shane Hostetter's CFO Role And TT Transformation Plan Promise Operational Excellence And Growth Surge
Operational efficiency improvements signaled by new CFO leadership and achievement in cost savings point towards better net margins and operating income.Chemours: We're Back Down To Trough And A 'BUY'
Sep 01Chemours: Upside After Irregularities, Good 2024-2026E
Jun 11The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement
May 30Drama At The Chemours Company Opens The Door For Upside
Mar 29The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%
Mar 01Chemours: The Case Amidst Board Trouble, I Say Buy The Weakness
Feb 29Chemours (NYSE:CC) Has Announced A Dividend Of $0.25
Feb 17Chemours: Technological Innovation Presents Excellent Opportunities For Growth
Dec 23Chemours (NYSE:CC) Will Pay A Dividend Of $0.25
Oct 30The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate
Oct 28Chemours: Volatile Bottom Line Needs Consistency
Oct 06The Chemours Company: Portfolio Optimization Resulting In Compounding Growth
Sep 19Stability and Growth of Payments
Fetching dividends data
Stable Dividend: CC's dividend payments have been volatile in the past 10 years.
Growing Dividend: CC's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Chemours Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CC) | 3.1% |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Chemicals) | 2.1% |
| Analyst forecast (CC) (up to 3 years) | 4.6% |
Notable Dividend: CC's dividend (3.13%) is higher than the bottom 25% of dividend payers in the US market (1.55%).
High Dividend: CC's dividend (3.13%) is low compared to the top 25% of dividend payers in the US market (4.67%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (534.7%), CC's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: CC is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 03:26 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Chemours Company is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Alembic Global Advisors |
| David Coleman | Argus Research Company |
| Ishan Majumdar | Baptista Research |